Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Sell
38
IPSEY Quote, Financials, Valuation and Earnings
Last price:
$29.38
Seasonality move
:
13.34%
Day range:
$29.38 - $30.03
52-week range:
$27.11 - $34.06
Dividend yield:
1.11%
P/E ratio:
12.43x
P/S ratio:
2.66x
P/B ratio:
2.24x
Volume:
702
Avg. volume:
7.7K
1-year change:
-1.67%
Market cap:
$9.7B
Revenue:
$3.9B
EPS (TTM):
$2.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Ipsen SA has -- downside to fair value with a price target of -- per share.
IPSEY vs. S&P 500
-
Over the past 5 trading days, Ipsen SA has overperformed the S&P 500 by 0.59% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ipsen SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ipsen SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Ipsen SA reported revenues of --.
Earnings Growth
-
Ipsen SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Ipsen SA reported earnings per share of --.
Enterprise value:
9.2B
EV / Invested capital:
--
Price / LTM sales:
2.66x
EV / EBIT:
10.27x
EV / Revenue:
2.49x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.42x
Price / Operating cash flow:
21.78x
Enterprise value / EBITDA:
8.16x
Gross Profit (TTM):
$3B
Return On Assets:
10.78%
Net Income Margin (TTM):
19.83%
Return On Equity:
--
Return On Invested Capital:
16.87%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | $893.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $2.1B | $2.7B | $1.9B | $2B | |
| Total Assets | $4.8B | $5.4B | $5.8B | $6.6B | $7B | |
| Current Liabilities | $1.5B | $1.3B | $1.4B | $1.9B | $1.8B | |
| Total Liabilities | $2.7B | $2.5B | $2.5B | $2.9B | $2.7B | |
| Total Equity | $2.1B | $2.8B | $3.2B | $3.7B | $4.3B | |
| Total Debt | $947.6M | $847.3M | $642.3M | $462.8M | $19.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-30 | 2024-03-30 | 2024-03-30 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
IPSEY
Sector
Market Cap
$9.7B
$36.5M
Price % of 52-Week High
86.26%
44.66%
Dividend Yield
1.11%
0%
Shareholder Yield
3.16%
-0.9%
1-Year Price Total Return
-1.67%
-39.9%
Beta (5-Year)
0.904
0.774
Dividend yield:
1.11%
Annualized payout:
$0.33
Payout ratio:
14.65%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$29.49
200-day SMA
Sell
Level
$29.97
Bollinger Bands (100)
Sell
Level
28.48 - 30.82
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Sell
Level
$29.71
Relative Strength Index (RSI14)
Sell
Level
48.04
ADX Line
Buy
Level
11.15
Williams %R
Neutral
Level
-67.4641
50-day SMA
Sell
Level
$30.13
MACD (12, 26)
Sell
Level
-0.18
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Sell
Level
-265.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4399)
Buy
CA Score
(Annual)
Level (0.663)
Buy
Beneish M-Score
(Annual)
Level (-2.2697)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.707)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.
Stock Forecast FAQ
In the current month, IPSEY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IPSEY average analyst price target in the past 3 months is --.
-
Where Will Ipsen SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ipsen SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Ipsen SA?
Analysts are divided on their view about Ipsen SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ipsen SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Ipsen SA's Price Target?
The price target for Ipsen SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IPSEY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ipsen SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IPSEY?
You can purchase shares of Ipsen SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ipsen SA shares.
-
What Is The Ipsen SA Share Price Today?
Ipsen SA was last trading at $29.38 per share. This represents the most recent stock quote for Ipsen SA. Yesterday, Ipsen SA closed at $29.38 per share.
-
How To Buy Ipsen SA Stock Online?
In order to purchase Ipsen SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
What Stocks Did Warren Buffett Just Buy?
In Q4 of last year, Warren Buffett added to or…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
